New twist in Fortis fight: Renuka Ramnath resigns from panel reviewing offers

A member of the external expert committee set up by the Fortis board to review offers for the company has resigned a day before the committee was to table its report of recommendations to the board. The reasons for this resignation are not clear at this point in time.

Multiples Equity founder Renuka Ramnath submitted her resignation from the expert advisory committee “due to her pre-occupation,” Fortis Healthcare told the Bombay Stock Exchange late on Wednesday.

“The same will be tabled before the board at the scheduled meeting on April 26, 2018 for their consideration and vacancy so caused shall be filled, by the board of directors, with a person of eminent repute,” Fortis stated.

Ramnath, who was the former MD and CEO of ICICI Venture, was to be part of a three member committee chaired by former PwC India CEO Deepak Kapoor. Lalit Bhasin, President, Society of Indian Law Firms and managing partner at Bhasin & Co is the third member of this committee.

The advisory panel was expected to review binding offers submitted by Manipal-TPG, Hero Enterprise Investment Office-Burman Family Office, IHH Healthcare Bhd and Radiant Life Care-KKR by April 25.

The committee’s recommendations would not be binding in nature but the Fortis board was expected to use this report to decide its further course of action in closing a deal.

While Fortis stated it received Ramnath’s resignation on April 25, it is not clear whether she had submitted her resignation on that date.

  • Related Posts

    Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

    Association of Indian Medical Device Industry (AiMeD) sends SOS to Union Minister Piyush Goel New Delhi: The war tremors have started shaking the domestic medical device industry perched on the…

    Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

    Dr D S Rana, Chairman, Sir Ganga Ram Trust Society was Cynosure of all Eyes New Delhi: Inaugural Conference of Critical Nephrology Society of India CNSICON 26 under the aegis…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory